Literature DB >> 35533663

Delirium Item Bank: Utilization to Evaluate and Create Delirium Instruments.

Benjamin K I Helfand1,2,3, Douglas Tommet2,3, Elke Detroyer4,5, Koen Milisen4,5, Dimitrios Adamis6,7, Eran D Metzger8,9, Edward R Marcantonio10, Edwin D Boudreaux1, Sharon K Inouye10,11,12, Richard N Jones2,3.   

Abstract

INTRODUCTION: The large number of heterogeneous instruments in active use for identification of delirium prevents direct comparison of studies and the ability to combine results. In a recent systematic review we performed, we recommended four commonly used and well-validated instruments and subsequently harmonized them using advanced psychometric methods to develop an item bank, the Delirium Item Bank (DEL-IB). The goal of the present study was to find optimal cut-points on four existing instruments and to demonstrate use of the DEL-IB to create new instruments.
METHODS: We used a secondary analysis and simulation study based on data from three previous studies of hospitalized older adults (age 65+ years) in the USA, Ireland, and Belgium. The combined dataset included 600 participants, contributing 1,623 delirium assessments, and an overall incidence of delirium of about 22%. The measurements included the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition diagnostic criteria for delirium, Confusion Assessment Method (long form and short form), Delirium Observation Screening Scale, Delirium Rating Scale-Revised-98 (total and severity scores), and Memorial Delirium Assessment Scale (MDAS).
RESULTS: We identified different cut-points for each existing instrument to optimize sensitivity or specificity, and compared instrument performance at each cut-point to the author-defined cut-point. For instance, the cut-point on the MDAS that maximizes both sensitivity and specificity was at a sum score of 6 yielding 89% sensitivity and 79% specificity. We then created four new example instruments (two short forms and two long forms) and evaluated their performance characteristics. In the first example short form instrument, the cut-point that maximizes sensitivity and specificity was at a sum score of 3 yielding 90% sensitivity, 81% specificity, 30% positive predictive value, and 99% negative predictive value. DISCUSSION/
CONCLUSION: We used the DEL-IB to better understand the psychometric performance of widely used delirium identification instruments and scorings, and also demonstrated its use to create new instruments. Ultimately, we hope that the DEL-IB might be used to create optimized delirium identification instruments and to spur the development of a unified approach to identify delirium.
© 2022 S. Karger AG, Basel.

Entities:  

Keywords:  Delirium; Item bank; Item response theory; Measurement; Psychometrics

Mesh:

Year:  2022        PMID: 35533663      PMCID: PMC9518700          DOI: 10.1159/000522522

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   3.346


  23 in total

1.  New Delirium Severity Indicators: Generation and Internal Validation in the Better Assessment of Illness (BASIL) Study.

Authors:  Sarinnapha M Vasunilashorn; Dena Schulman-Green; Douglas Tommet; Tamara G Fong; Tammy T Hshieh; Edward R Marcantonio; Eran D Metzger; Eva M Schmitt; Patricia A Tabloski; Thomas G Travison; Yun Gou; Benjamin Helfand; Sharon K Inouye; Richard N Jones
Journal:  Dement Geriatr Cogn Disord       Date:  2020-06-17       Impact factor: 2.959

2.  Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection.

Authors:  Marcus D Ruopp; Neil J Perkins; Brian W Whitcomb; Enrique F Schisterman
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

3.  Clarifying confusion: the confusion assessment method. A new method for detection of delirium.

Authors:  S K Inouye; C H van Dyck; C A Alessi; S Balkin; A P Siegal; R I Horwitz
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

4.  Detection of delirium in palliative care unit patients: a prospective descriptive study of the Delirium Observation Screening Scale administered by bedside nurses.

Authors:  Elke Detroyer; Paul M Clement; Nele Baeten; Michèle Pennemans; Marleen Decruyenaere; Joris Vandenberghe; Johan Menten; Etienne Joosten; Koen Milisen
Journal:  Palliat Med       Date:  2013-06-06       Impact factor: 4.762

5.  A comparison of delirium diagnosis in elderly medical inpatients using the CAM, DRS-R98, DSM-IV and DSM-5 criteria.

Authors:  Dimitrios Adamis; Siobhan Rooney; David Meagher; Owen Mulligan; Geraldine McCarthy
Journal:  Int Psychogeriatr       Date:  2015-01-20       Impact factor: 3.878

6.  Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis.

Authors:  Joost Witlox; Lisa S M Eurelings; Jos F M de Jonghe; Kees J Kalisvaart; Piet Eikelenboom; Willem A van Gool
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

7.  Harmonization of Four Delirium Instruments: Creating Crosswalks and the Delirium Item-Bank (DEL-IB).

Authors:  Benjamin K I Helfand; Elke Detroyer; Koen Milisen; Dimitrios Adamis; Eran D Metzger; Edwin D Boudreaux; Sharon K Inouye; Richard N Jones
Journal:  Am J Geriatr Psychiatry       Date:  2021-07-29       Impact factor: 4.105

8.  Nurses' Recognition of Hospitalized Older Patients With Delirium and Cognitive Impairment Using the Delirium Observation Screening Scale: A Prospective Comparison Study.

Authors:  Wolfgang Hasemann; Debbie Tolson; Jon Godwin; Rebecca Spirig; Irena Anna Frei; Reto W Kressig
Journal:  J Gerontol Nurs       Date:  2018-12-01       Impact factor: 1.254

9.  Delirium diagnosis methodology used in research: a survey-based study.

Authors:  Karin J Neufeld; Archana Nelliot; Sharon K Inouye; E Wesley Ely; O Joseph Bienvenu; Hochang Benjamin Lee; Dale M Needham
Journal:  Am J Geriatr Psychiatry       Date:  2014-03-15       Impact factor: 4.105

Review 10.  Delirium in Older Persons: Advances in Diagnosis and Treatment.

Authors:  Esther S Oh; Tamara G Fong; Tammy T Hshieh; Sharon K Inouye
Journal:  JAMA       Date:  2017-09-26       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.